Selected research
Market Analysis & Forecast
Global Biomarker Discovery Outsourcing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Biomarker Discovery Outsourcing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Biomarker Discovery Outsourcing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Biomarker Discovery Outsourcing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Biomarker Discovery Outsourcing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Biomarker Discovery Outsourcing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Biomarker Discovery Outsourcing Services include Laboratory Corporation of America Holdings, GHO Capital, ICON plc, Agilent, Proteome Sciences, Charles River Laboratories., Eurofins Scientific, Celerion and Evotec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biomarker Discovery Outsourcing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biomarker Discovery Outsourcing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomarker Discovery Outsourcing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biomarker Discovery Outsourcing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomarker Discovery Outsourcing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomarker Discovery Outsourcing Services revenue, projected growth trends, production technology, application and end-user industry.
Biomarker Discovery Outsourcing Services Segment by Company
Laboratory Corporation of America Holdings
GHO Capital
ICON plc
Agilent
Proteome Sciences
Charles River Laboratories.
Eurofins Scientific
Celerion
Evotec
Parexel International (MA) Corporation
Biomarker Discovery Outsourcing Services Segment by Type
Predictive biomarkers
Safety biomarkers
Prognostic biomarkers
Others
Biomarker Discovery Outsourcing Services Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
Biomarker Discovery Outsourcing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Discovery Outsourcing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarker Discovery Outsourcing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Discovery Outsourcing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biomarker Discovery Outsourcing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biomarker Discovery Outsourcing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarker Discovery Outsourcing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Predictive biomarkers
- Safety biomarkers
- Prognostic biomarkers
- Others
Applications
- Biotechnology Company
- Pharmaceutical Company
- Others
Companies covered
- Laboratory Corporation of America Holdings
- GHO Capital
- ICON plc
- Agilent
- Proteome Sciences
- Charles River Laboratories.
- Eurofins Scientific
- Celerion
- Evotec
- Parexel International (MA) Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biomarker Discovery Outsourcing Services Market by Type
- 1.2.1 Global Biomarker Discovery Outsourcing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Predictive biomarkers
- 1.2.3 Safety biomarkers
- 1.2.4 Prognostic biomarkers
- 1.2.5 Others
- 1.3 Biomarker Discovery Outsourcing Services Market by Application
- 1.3.1 Global Biomarker Discovery Outsourcing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Biotechnology Company
- 1.3.3 Pharmaceutical Company
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biomarker Discovery Outsourcing Services Market Dynamics
- 2.1 Biomarker Discovery Outsourcing Services Industry Trends
- 2.2 Biomarker Discovery Outsourcing Services Industry Drivers
- 2.3 Biomarker Discovery Outsourcing Services Industry Opportunities and Challenges
- 2.4 Biomarker Discovery Outsourcing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biomarker Discovery Outsourcing Services Market Perspective (2021-2032)
- 3.2 Global Biomarker Discovery Outsourcing Services Growth Trends by Region
- 3.2.1 Global Biomarker Discovery Outsourcing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biomarker Discovery Outsourcing Services Market Size by Region (2021-2026)
- 3.2.3 Global Biomarker Discovery Outsourcing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biomarker Discovery Outsourcing Services Revenue by Players
- 4.1.1 Global Biomarker Discovery Outsourcing Services Revenue by Players (2021-2026)
- 4.1.2 Global Biomarker Discovery Outsourcing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biomarker Discovery Outsourcing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biomarker Discovery Outsourcing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biomarker Discovery Outsourcing Services Key Players Headquarters & Area Served
- 4.4 Global Biomarker Discovery Outsourcing Services Players, Product Type & Application
- 4.5 Global Biomarker Discovery Outsourcing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biomarker Discovery Outsourcing Services Market CR5 and HHI
- 4.6.3 2025 Biomarker Discovery Outsourcing Services Tier 1, Tier 2, and Tier 3
5 Biomarker Discovery Outsourcing Services Market Size by Type
- 5.1 Global Biomarker Discovery Outsourcing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 5.3 Global Biomarker Discovery Outsourcing Services Revenue Market Share by Type (2021-2032)
6 Biomarker Discovery Outsourcing Services Market Size by Application
- 6.1 Global Biomarker Discovery Outsourcing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 6.3 Global Biomarker Discovery Outsourcing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Laboratory Corporation of America Holdings
- 7.1.1 Laboratory Corporation of America Holdings Company Information
- 7.1.2 Laboratory Corporation of America Holdings Business Overview
- 7.1.3 Laboratory Corporation of America Holdings Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 Laboratory Corporation of America Holdings Biomarker Discovery Outsourcing Services Product Portfolio
- 7.1.5 Laboratory Corporation of America Holdings Recent Developments
- 7.2 GHO Capital
- 7.2.1 GHO Capital Company Information
- 7.2.2 GHO Capital Business Overview
- 7.2.3 GHO Capital Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 GHO Capital Biomarker Discovery Outsourcing Services Product Portfolio
- 7.2.5 GHO Capital Recent Developments
- 7.3 ICON plc
- 7.3.1 ICON plc Company Information
- 7.3.2 ICON plc Business Overview
- 7.3.3 ICON plc Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 ICON plc Biomarker Discovery Outsourcing Services Product Portfolio
- 7.3.5 ICON plc Recent Developments
- 7.4 Agilent
- 7.4.1 Agilent Company Information
- 7.4.2 Agilent Business Overview
- 7.4.3 Agilent Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 Agilent Biomarker Discovery Outsourcing Services Product Portfolio
- 7.4.5 Agilent Recent Developments
- 7.5 Proteome Sciences
- 7.5.1 Proteome Sciences Company Information
- 7.5.2 Proteome Sciences Business Overview
- 7.5.3 Proteome Sciences Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Proteome Sciences Biomarker Discovery Outsourcing Services Product Portfolio
- 7.5.5 Proteome Sciences Recent Developments
- 7.6 Charles River Laboratories.
- 7.6.1 Charles River Laboratories. Company Information
- 7.6.2 Charles River Laboratories. Business Overview
- 7.6.3 Charles River Laboratories. Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 Charles River Laboratories. Biomarker Discovery Outsourcing Services Product Portfolio
- 7.6.5 Charles River Laboratories. Recent Developments
- 7.7 Eurofins Scientific
- 7.7.1 Eurofins Scientific Company Information
- 7.7.2 Eurofins Scientific Business Overview
- 7.7.3 Eurofins Scientific Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Eurofins Scientific Biomarker Discovery Outsourcing Services Product Portfolio
- 7.7.5 Eurofins Scientific Recent Developments
- 7.8 Celerion
- 7.8.1 Celerion Company Information
- 7.8.2 Celerion Business Overview
- 7.8.3 Celerion Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Celerion Biomarker Discovery Outsourcing Services Product Portfolio
- 7.8.5 Celerion Recent Developments
- 7.9 Evotec
- 7.9.1 Evotec Company Information
- 7.9.2 Evotec Business Overview
- 7.9.3 Evotec Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Evotec Biomarker Discovery Outsourcing Services Product Portfolio
- 7.9.5 Evotec Recent Developments
- 7.10 Parexel International (MA) Corporation
- 7.10.1 Parexel International (MA) Corporation Company Information
- 7.10.2 Parexel International (MA) Corporation Business Overview
- 7.10.3 Parexel International (MA) Corporation Biomarker Discovery Outsourcing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Parexel International (MA) Corporation Biomarker Discovery Outsourcing Services Product Portfolio
- 7.10.5 Parexel International (MA) Corporation Recent Developments
8 North America
- 8.1 North America Biomarker Discovery Outsourcing Services Revenue (2021-2032)
- 8.2 North America Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 8.2.1 North America Biomarker Discovery Outsourcing Services Revenue by Type (2021-2026)
- 8.2.2 North America Biomarker Discovery Outsourcing Services Revenue by Type (2027-2032)
- 8.3 North America Biomarker Discovery Outsourcing Services Revenue Share by Type (2021-2032)
- 8.4 North America Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 8.4.1 North America Biomarker Discovery Outsourcing Services Revenue by Application (2021-2026)
- 8.4.2 North America Biomarker Discovery Outsourcing Services Revenue by Application (2027-2032)
- 8.5 North America Biomarker Discovery Outsourcing Services Revenue Share by Application (2021-2032)
- 8.6 North America Biomarker Discovery Outsourcing Services Revenue by Country
- 8.6.1 North America Biomarker Discovery Outsourcing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biomarker Discovery Outsourcing Services Revenue by Country (2021-2026)
- 8.6.3 North America Biomarker Discovery Outsourcing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biomarker Discovery Outsourcing Services Revenue (2021-2032)
- 9.2 Europe Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Biomarker Discovery Outsourcing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Biomarker Discovery Outsourcing Services Revenue by Type (2027-2032)
- 9.3 Europe Biomarker Discovery Outsourcing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Biomarker Discovery Outsourcing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Biomarker Discovery Outsourcing Services Revenue by Application (2027-2032)
- 9.5 Europe Biomarker Discovery Outsourcing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Biomarker Discovery Outsourcing Services Revenue by Country
- 9.6.1 Europe Biomarker Discovery Outsourcing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biomarker Discovery Outsourcing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Biomarker Discovery Outsourcing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biomarker Discovery Outsourcing Services Revenue (2021-2032)
- 10.2 China Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 10.2.1 China Biomarker Discovery Outsourcing Services Revenue by Type (2021-2026)
- 10.2.2 China Biomarker Discovery Outsourcing Services Revenue by Type (2027-2032)
- 10.3 China Biomarker Discovery Outsourcing Services Revenue Share by Type (2021-2032)
- 10.4 China Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 10.4.1 China Biomarker Discovery Outsourcing Services Revenue by Application (2021-2026)
- 10.4.2 China Biomarker Discovery Outsourcing Services Revenue by Application (2027-2032)
- 10.5 China Biomarker Discovery Outsourcing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biomarker Discovery Outsourcing Services Revenue (2021-2032)
- 11.2 Asia Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Biomarker Discovery Outsourcing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Biomarker Discovery Outsourcing Services Revenue by Type (2027-2032)
- 11.3 Asia Biomarker Discovery Outsourcing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Biomarker Discovery Outsourcing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Biomarker Discovery Outsourcing Services Revenue by Application (2027-2032)
- 11.5 Asia Biomarker Discovery Outsourcing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Biomarker Discovery Outsourcing Services Revenue by Country
- 11.6.1 Asia Biomarker Discovery Outsourcing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biomarker Discovery Outsourcing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Biomarker Discovery Outsourcing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biomarker Discovery Outsourcing Services Revenue (2021-2032)
- 12.2 SAMEA Biomarker Discovery Outsourcing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biomarker Discovery Outsourcing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biomarker Discovery Outsourcing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Biomarker Discovery Outsourcing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biomarker Discovery Outsourcing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biomarker Discovery Outsourcing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biomarker Discovery Outsourcing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Biomarker Discovery Outsourcing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biomarker Discovery Outsourcing Services Revenue by Country
- 12.6.1 SAMEA Biomarker Discovery Outsourcing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biomarker Discovery Outsourcing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biomarker Discovery Outsourcing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst